79418-77-2

Upstream product

• 71924-62-4 2-fluoro-4,5-dimethoxybenzaldehyde 
• 141523-16-2 4-Benzyloxy-2-fluoro-5-hydroxybenzaldehyde 
• 79418-72-7 4-Benzyloxy-2-fluoro-5-methoxybenzaldehyde 

Downstream Products

• 1036383-52-4 4-(5,6-dichloro-1H-benzoimidazol-2-ylmethoxy)-2-fluoro-5-methoxy-benzaldehyde 
• 918524-87-5 4-(1H-benzimidazol-2-ylmethoxy)-2-fluoro-5-methoxy-benzaldehyde 
• 1036383-47-7 2-fluoro-5-methoxy-4-(1-methyl-1H-benzimidazol-2-ylmethoxy)-benzaldehyde 
• 918524-91-1 4-(3-diethylamino-propoxy)-2-fluoro-5-methoxy-benzaldehyde 
• 1036383-57-9 2-(5-fluoro-4-formyl-2 methoxy-phenoxymethyl)-1H-benzoimidazole-5-sulfonic acid dimethylamide 
• 79418-72-7 4-Benzyloxy-2-fluoro-5-methoxybenzaldehyde 

Relevant academic research and scientific papers

cGAS ANTAGONIST COMPOUNDS

Disclosed are novel compounds of Formula (I) that are cGAS antagonists, methods of preparation of the compounds, pharmaceutical compositions comprising the compounds, and their use in medical therapy.

COMPOUNDS AND METHODS FOR KINASE MODULATION, AND INDICATIONS THEREFOR

Compounds active on protein kinases are described, as well as methods of using such compounds to treat diseases and conditions associated with aberrant activity of protein kinases.

PYRROLO [2,3-B] PYRIDINES AS KINASE MODULATORS

Compounds active on protein kinases are described, as well as methods of using such compounds to treat diseases and conditions associated with aberrant activity of protein kinases.

PYRROLO[2,3-B] PYRIDINE DERIVATIVES AS PROTEIN KINASE INHIBITORS

Compounds of formula III which are active on protein kinases are described, as well as methods of using such compounds to treat diseases and conditions associated with aberrant activity of protein kinases.